MedPath

Effect of Red Meat Intake on Occurrence of Serum Non-transferrin Bound Iron (NTBI)

Not Applicable
Conditions
Healthy
Registration Number
NCT03019393
Lead Sponsor
Thomas Walczyk
Brief Summary

This study aims to evaluate the effect of red meat intake on occurrence of non-transferrin bound iron (NTBI)

Detailed Description

During Visit 1, blood samples will be collected to assess iron status. During Visit 2, after an overnight fast, participant will be given a standardized meal (rice and potatoes) with a portion of cooked beef (200 g). Blood samples will be collected right before and 2 hour after the meal for NTBI analysis.

NTBI concentration before and after meal consumption will be compared.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
15
Inclusion Criteria
  • Apparently healthy male volunteers (21 - 45 years old)
  • C-reactive protein (CRP) < 5 mg/L
Exclusion Criteria
  • Blood donation or significant blood loss (e.g. surgery) within the past 4 months
  • Regular intake of iron and other nutrient supplements within the past 4 months
  • Regular intake of medication except oral contraceptives
  • Acute or recent inflammatory or infectious symptoms
  • Chronic gastrointestinal disorders or metabolic diseases
  • Smoking
  • Coeliac disease or gluten-related disorders
  • Iron deficiency anemia (Hb < 14 g/dL for males) with serum ferritin concentration < 30 ng/mL)
  • Non-iron deficiency anemia (serum ferritin concentration within normal range (30 - 300 ng/mL for males) but low hemoglobin (< 14 g/dL for males)
  • Iron overload conditions (serum ferritin concentration > 300 ng/mL for males)
  • Known hereditary disorders of iron metabolism

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Occurrence of serum non-transferrin bound iron (NTBI) after consumption of red meat2 hour post meal administration

Blood samples collected 2 h after consumption of red meat will be analyzed for non-transferrin bound iron (NTBI) concentration

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National University of Singapore; National University Hospital

🇸🇬

Singapore, Singapore

National University of Singapore; National University Hospital
🇸🇬Singapore, Singapore

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.